- Home
- GFAI vs IGC Comparison
GFAI vs IGC Comparison
Compare GFAI & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GFAI
- IGC
- Stock Information
- Founded
- GFAI 2018
- IGC 2005
- Country
- GFAI Singapore
- IGC United States
- Employees
- GFAI N/A
- IGC N/A
- Industry
- GFAI Diversified Commercial Services
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- GFAI Consumer Discretionary
- IGC Health Care
- Exchange
- GFAI Nasdaq
- IGC Nasdaq
- Market Cap
- GFAI 23.3M
- IGC 33.5M
- IPO Year
- GFAI N/A
- IGC N/A
- Fundamental
- Price
- GFAI $1.21
- IGC $0.37
- Analyst Decision
- GFAI Strong Buy
- IGC Strong Buy
- Analyst Count
- GFAI 1
- IGC 2
- Target Price
- GFAI $4.50
- IGC $3.88
- AVG Volume (30 Days)
- GFAI 722.9K
- IGC 7.6M
- Earning Date
- GFAI 09-23-2025
- IGC 08-07-2025
- Dividend Yield
- GFAI N/A
- IGC N/A
- EPS Growth
- GFAI N/A
- IGC N/A
- EPS
- GFAI N/A
- IGC N/A
- Revenue
- GFAI $36,347,373.00
- IGC $1,271,000.00
- Revenue This Year
- GFAI $5.66
- IGC $15.26
- Revenue Next Year
- GFAI $4.69
- IGC $3.41
- P/E Ratio
- GFAI N/A
- IGC N/A
- Revenue Growth
- GFAI 0.18
- IGC N/A
- 52 Week Low
- GFAI $0.76
- IGC $0.25
- 52 Week High
- GFAI $3.88
- IGC $0.48
- Technical
- Relative Strength Index (RSI)
- GFAI 46.47
- IGC 54.87
- Support Level
- GFAI $1.27
- IGC $0.35
- Resistance Level
- GFAI $1.48
- IGC $0.39
- Average True Range (ATR)
- GFAI 0.10
- IGC 0.04
- MACD
- GFAI -0.01
- IGC 0.00
- Stochastic Oscillator
- GFAI 19.44
- IGC 35.71
About GFAI Guardforce AI Co. Limited
Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.